ALGN

$149.892.49%-3.82

Align Technology Inc (ALGN)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$153.71

Offen:

$153.98

24-Stunden-Volumen:

1,119,630

Relatives Volumen:

1.05

Marktkapitalisierung:

$10.65B

Einnahmen:

$4.10B

Nettoeinkommen (Verlust:

$429.89M

KGV:

25.12

EPS:

$5.97

Netto-Cashflow:

$583.65M

1W Leistung:

-2.99%

1M Leistung:

+3.12%

6M Leistung:

-14.84%

1Y Leistung:

+8.28%

1-Tages-Spanne:

$147.52$155.54

1-Wochen-Bereich:

$147.52$156.50

52-Wochen-Spanne:

$130.23$200.44

Align Technology Inc Aktie (ALGN) Unternehmensprofil

Firmenname

Align Technology Inc

Sektor

Healthcare

Branche

Medical Instruments & Supplies

Telefon

408-470-1000

Adresse

410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA, USA

Mitarbeiter

20,290

@AlignTechInc

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

ALGN-Diskussionen auf X

ALGN vs. ISRG, BDX, ALC, RMD, WST vergleichen

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALGN Align Technology Inc	$149.89	$10.65B	$4.10B	$429.89M	$583.65M	$5.97
ISRG Intuitive Surgical Inc	$432.01	$152.62B	$11.03B	$3.16B	$3.22B	$8.73
BDX Becton Dickinson Co	$197.88	$53.90B	$21.37B	$1.41B	$3.07B	$3.94
ALC Alcon Inc	$71.45	$34.54B	$10.63B	$819.00M	$1.59B	$1.66
RMD Resmed Inc	$229.94	$32.34B	$5.54B	$1.52B	$1.74B	$10.37
WST West Pharmaceutical Services Inc	$412.62	$28.79B	$3.22B	$542.70M	$458.00M	$7.48

Align Technology Inc Aktie (ALGN) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-15	Herabstufung	Robert W. Baird	Outperform → Neutral
2026-10-05	Herabstufung	Evercore ISI	Outperform → In-line
2026-07-09	Eingeleitet	BMO Capital Markets	Outperform
2026-04-15	Eingeleitet	Citigroup	Buy
2026-03-17	Hochstufung	Barclays	Equal Weight → Overweight
2026-02-09	Hochstufung	HSBC Securities	Hold → Buy
2025-12-09	Eingeleitet	Barclays	Equal Weight
2025-10-10	Herabstufung	Jefferies	Buy → Hold
2025-07-31	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-04-25	Herabstufung	HSBC Securities	Buy → Hold
2025-02-14	Eingeleitet	Wells Fargo	Overweight
2025-01-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-12-04	Eingeleitet	Mizuho	Outperform
2024-10-10	Eingeleitet	Needham	Hold
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-11	Herabstufung	Goldman	Neutral → Sell
2023-10-27	Herabstufung	UBS	Buy → Neutral
2023-02-02	Hochstufung	Goldman	Sell → Neutral
2022-07-28	Herabstufung	Goldman	Buy → Sell
2022-01-31	Eingeleitet	Morgan Stanley	Overweight
2022-01-31	Hochstufung	UBS	Neutral → Buy
2021-10-01	Resumed	Credit Suisse	Outperform
2021-08-05	Resumed	Credit Suisse	Outperform
2021-07-09	Hochstufung	Stephens	Equal-Weight → Overweight
2021-07-08	Eingeleitet	Exane BNP Paribas	Outperform
2021-04-22	Hochstufung	Berenberg	Hold → Buy
2021-01-04	Hochstufung	Evercore ISI	In-line → Outperform
2020-07-29	Herabstufung	Berenberg	Buy → Hold
2020-07-20	Herabstufung	BofA Securities	Neutral → Underperform
2020-01-09	Hochstufung	Wolfe Research	Peer Perform → Outperform
2019-10-24	Bestätigt	BofA/Merrill	Neutral
2019-10-07	Herabstufung	Guggenheim	Buy → Neutral
2019-07-25	Herabstufung	Evercore ISI	Outperform → In-line
2019-05-30	Eingeleitet	Wolfe Research	Peer Perform
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-02-14	Herabstufung	UBS	Buy → Neutral
2019-01-17	Eingeleitet	UBS	Buy
2018-11-20	Bestätigt	Credit Suisse	Outperform
2018-07-26	Bestätigt	Stifel	Buy
2018-07-13	Bestätigt	Stifel	Buy
2018-06-25	Resumed	BofA/Merrill	Buy
2018-05-22	Bestätigt	Stifel	Buy
2018-05-17	Eingeleitet	Evercore ISI	Outperform
2018-04-26	Bestätigt	Stifel	Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-04-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-03-08	Eingeleitet	Barclays	Overweight

Finanzdaten der Align Technology Inc-Aktie (ALGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Align Technology Inc-Aktie (ALGN) Insiderhandel

SIEGEL SUSAN EMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
10,723
Saia Andrea LynnMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
17,318
Poul MojdehMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
3,553
Myong AnneMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
9,830
LARKIN C RAYMOND JRMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
2,326
Wert ($)
0
#Aktien Gesamt
27,454
Dallas Kevin JMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
16,168
LACOB JOSEPHMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
135,916
Conroy Kevin TMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
3,553
MORROW GEORGE JMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
5,036
Morici JohnFeb 20 '26
EVP, CHIEF FINANCIAL OFFICER
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
7,848
Wert ($)
0
#Aktien Gesamt
16,085

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	#Aktien Gesamt
SIEGEL SUSAN E	Director	May 20 '26	Option Exercise	$0.00	1,745	10,723
Saia Andrea Lynn	Director	May 20 '26	Option Exercise	$0.00	1,745	17,318
Poul Mojdeh	Director	May 20 '26	Option Exercise	$0.00	1,745	3,553
Myong Anne	Director	May 20 '26	Option Exercise	$0.00	1,745	9,830
LARKIN C RAYMOND JR	Director	May 20 '26	Option Exercise	$0.00	2,326	27,454
Dallas Kevin J	Director	May 20 '26	Option Exercise	$0.00	1,745	16,168
LACOB JOSEPH	Director	May 20 '26	Option Exercise	$0.00	1,745	135,916
Conroy Kevin T	Director	May 20 '26	Option Exercise	$0.00	1,745	3,553
MORROW GEORGE J	Director	May 20 '26	Option Exercise	$0.00	1,745	5,036
Morici John	EVP, CHIEF FINANCIAL OFFICER	Feb 20 '26	Option Exercise	$0.00	7,848	16,085

Align Technology Inc Aktie (ALGN) Neueste Nachrichten

Oct 29, 2026

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls - Zacks Investment Research

Oct 29, 2026

Oct 27, 2026

Align Technology (ALGN) Heads Into Earnings As Undervalued Case Faces A Fresh Test - Yahoo Finance

Oct 27, 2026

UBS Adjusts Price Target on Align Technology to $186 From $205, Maintains Neutral Rating - Moomoo

Oct 27, 2026

UBS Adjusts Price Target on Align Technology to $186 From $205, Maintains Neutral Rating - marketscreener.com

Oct 27, 2026

Is the Options Market Predicting a Spike in Align Technology Stock? - Zacks Investment Research

Oct 27, 2026

What to expect from Align Technology’s (ALGN) Q3 earnings - Yahoo Finance

Oct 27, 2026

Is the Options Market Predicting a Spike in Align Technology Stock? - TradingView

Oct 27, 2026